Several GLP-1 receptor agonists are currently licensed for use in the UK, including semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Bydureon BCise), and lixisenatide (Lyxumia)
Customizing GLP-1 medication dosages for patients with chronic kidney disease (CKD) is a critical step to ensure treatments are both safe and effective
Its a quick procedure but might need multiple sessions
Capitalize on the GLP-1 Market Opportunity With BevSource Now is the perfect time for beverage brands to invest in beverages that target opportunities both during and after GLP-1 treatment, with products focusing on functional benefits and nutritional support
Neurocognitive and Mood Support Peptides Peptides such as Selank, Semax, and Epitalon help modulate the limbic system, reduce anxiety, and improve cognitive clarityespecially in the context of limbic dysregulation, neuroinflammation, or post-infectious fatigue